Trials / Withdrawn
WithdrawnNCT02752230
Comparison of Exparel to Marcaine in Post-Surgical Analgesia in Bariatrics
Comparison of Exparel (Bupivacaine Liposome) to Marcaine (Bupivacaine) in Post-Surgical Analgesia for Laparoscopic Trocar Site Incisions in Bariatric Surgery
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Kettering Health Network · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to evaluate the use of bupivacaine liposome 1.3% compared bupivacaine 0.5% in pain control in post-operative laparoscopic bariatric surgery patient The purpose of this study is to evaluate two local anesthetics and determine if there is an advantage of administering one medication compared over the other. The intent is show that one local anesthetic.allows for improved pain control as per the pain scale ratings of the test subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laparoscopic Roux en Y gastric bypass | Laparoscopic Roux en Y gastric bypass |
| PROCEDURE | Laparoscopic Sleeve Gastrectomy | Laparoscopic Sleeve Gastrectomy |
Timeline
- Start date
- 2016-11-29
- Primary completion
- 2020-06-01
- Completion
- 2021-06-01
- First posted
- 2016-04-26
- Last updated
- 2020-07-15
Source: ClinicalTrials.gov record NCT02752230. Inclusion in this directory is not an endorsement.